NDRG1 and central nervous system cancer: Thomas et al indicated that the expression of NDRG1 was markedly upregulated during hypoxia in glioma, and that an NDRG1‐overexpressing glioma implantation model with reduced angiogenic activity reduced the rate of glioma growth and resistance to antiangiogenic treatment.